Arasertaconazole Nitrate Pessaries - Dose Finding Study for the Vulvovaginal Candidiasis (VVC) Treatment
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
In order to find an optimal dose of arasertaconazole nitrate in the treatment of vulvovaginal
candidiasis, a multicenter, randomized, double-blind, parallel, placebo-controlled study will
be conducted to compare the therapeutic efficacy, safety and tolerability of three different
doses of arasertaconazole nitrate (150 mg, 300 mg or 600 mg, pessaries).